@article{poizeau:hal-02303760, TITLE = {{Early major adverse cardiovascular events following the initiation of the anti-interleukin 12/23 antibody ustekinumab. A population-based case-time-control study}}, AUTHOR = {Poizeau, F. and Nowak, E. and Kerbrat, S. and Droitcourt, C. and Sbidian, E. and Guillot, B. and Bachelez, H. and Ait-Oufella, H. and Oger, E. and Dupuy, A.}, URL = {https://univ-rennes.hal.science/hal-02303760}, JOURNAL = {{Journal of Investigative Dermatology}}, PUBLISHER = {{Nature Publishing Group}}, VOLUME = {139}, NUMBER = {9}, PAGES = {S230-S230}, YEAR = {2019}, MONTH = Sep, DOI = {10.1016/j.jid.2019.07.097}, KEYWORDS = {Ustekinumab ; Major adverse cardiovascular events (MACE) ; Monoclonal antibody ; Cardiovascular risk}, HAL_ID = {hal-02303760}, HAL_VERSION = {v1}, }